Table 1.
Summary of demographics and conventional coronary heart disease (CHD) risk factors at the eighth examination cycle for the 1180 and 524 individuals in the training and test sets, respectively.
| Training (n = 1180) | Test (n = 524) | |||
|---|---|---|---|---|
| CHD 1 | No CHD 2 | CHD 1 | No CHD 2 | |
| Gender (count) | ||||
| Male | 23 | 462 | 12 | 219 |
| Female | 19 | 676 | 8 | 285 |
| Age (years) | ||||
| Male | 70.8 ± 9.7 | 65.2 ± 8.1 | 66.8 ± 7.5 | 61.6 ± 8.6 |
| Female | 68.5 ± 9.0 | 65.6 ± 8.2 | 70.3 ± 10.7 | 63.8 ± 9.1 |
| Total Cholesterol (mg/dL) | ||||
| Male | 166 ± 50 | 178 ± 32 | 173 ± 34 | 185 ± 32 |
| Female | 204 ± 50 | 201 ± 36 | 181 ± 38 | 196 ± 33 |
| HDL Cholesterol (mg/dL) | ||||
| Male | 48 ± 15 | 50 ± 14 | 49 ± 17 | 51 ± 15 |
| Female | 53 ± 16 | 66 ± 19 | 60 ± 19 | 66 ± 19 |
| HbA1c (%) | ||||
| Male | 5.8 ± 0.4 | 5.7 ± 0.8 | 5.7 ± 0.7 | 5.6 ± 0.5 |
| Female | 5.9 ± 0.8 | 5.7 ± 0.5 | 5.6 ± 0.4 | 5.6 ± 0.5 |
| SBP (mmHg) | ||||
| Male | 134 ± 17 | 130 ± 17 | 138 ± 25 | 128 ± 16 |
| Female | 137 ± 19 | 128 ± 18 | 135 ± 24 | 125 ± 17 |
| DBP (mmHg) | ||||
| Male | 73 ± 11 | 77 ± 10 | 75 ± 8 | 78 ± 9 |
| Female | 77 ± 9 | 73 ± 10 | 66 ± 10 | 73 ± 10 |
| Smoker (count) | ||||
| Male | 1 (4%) | 29 (6%) | 3 (25%) | 12 (5%) |
| Female | 2 (11%) | 49 (7%) | 0 (0%) | 28 (10%) |
| Blood Pressure Treatment (count) | ||||
| Male | 16 (70%) | 223 (48%) | 7 (58%) | 86 (39%) |
| Female | 10 (53%) | 250 (37%) | 4 (50%) | 114 (40%) |
1 Those who developed symptomatic coronary heart disease (CHD) within five years of contributing biomaterial during the Offspring cohort eighth examination cycle. 2 Those who did not develop symptomatic CHD within five years of contributing biomaterial during the Offspring cohort eighth examination cycle. HDL: high-density lipoprotein, SBP: systolic blood pressure, DBP: diastolic blood pressure.